You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
現代製藥(600420.SH):青海生物藥品廠通過了獸藥GMP驗收並取得證書
格隆匯 11-12 18:57

格隆匯 11 月 12日丨現代製藥(600420.SH)公佈,近日公司控股子公司青海製藥(集團)有限責任公司之全資子公司青海生物藥品廠有限公司(“青海生藥品廠”)通過了獸藥GMP驗收,並收到青海省農業農村廳核發《獸藥生產許可證》和《獸藥GMP證書》。

驗收範圍:細菌滅活疫苗、細菌活疫苗(布氏菌病活疫苗除外)、炭疽芽孢苗、細胞毒活疫苗生產線

涉及生產線產能及主要產品情況:

青海生物藥品廠此次取得《獸藥生產許可證》和《獸藥GMP證書》為原有證書到期後進行的再認證,説明了該公司相關生產線滿足《獸藥生產質量管理規範》要求,有關產品生產將滿足質量標準和安全標準,有利於繼續保持穩定的生產能力,滿足市場需求。

此次青海生物藥品廠通過GMP驗收,不會對公司當前經營產生重大影響。由於產品的銷售受到國家政策、市場環境等因素影響,存在不確定性,敬請廣大投資者謹慎決策,注意防範投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account